Invest in intelligence that delivers

Contact

Perspective
is everything.

Across the pharma lifecycle, an accurate and complete market view is essential to stay ahead of the curve and uncover emerging healthcare trends.

Visit our portal

Think beyond the brand.

The more you understand the landscape, the better you can align with market needs and gain a competitive edge.

Identify:

  • Unmet market, prescriber, and patient needs 
  • Disconnect between what prescribers say versus what they do 
  • Access barriers, payer expectations, and reimbursement drivers
  • Gaps, threats, and disruptors 

Broaden your
perspective,
with Spherix.

We combine robust, independent market data with deep expertise across therapeutic areas, payers, physicians, and patients—maintaining an unwavering focus on delivering measurable commercial value.

Harness the power of holistic market intelligence. Make better decisions and unlock opportunities.

We view the market landscape through the lens of your business and deliver customized strategic advisory services.

Spherix delivers:

Market Insights

Gain an unbiased perspective of the market and its potential, independently assess launches, understand the patient journey and perspectives of the prescribers, optimize market access strategies, and gauge the impact of disruptive events.

Strategic Sessions

Interactive on-site or virtual  sessions with Spherix market experts, highlighting commercially relevant analyses, contextual data, and custom insights tailored to your business.

Advisory Services

Fortify your strategy and tactics with our industry experts who are well-equipped to deliver strategic advisory services across the product lifecycle.

Spherix is dedicated to the market areas we cover.

Learn more about the specialty markets we cover

Commercial Market Landscape

  • Commercial Pharmacy Benefits
  • Commercial Medical Benefits
  • Employer Trends

Government

  • Medicare Part D Benefits
  • Medicare Part B Benefits
  • Medicaid, Exchanges & Other Programs

Account Comparisons

  • Leading Payers
  • Blues & Regional Plans
  • Integrated Delivery Networks
  • Specialty Pharmacies

Account Profiles

  • Leading account profiles
  • Blues and regional plan profiles
  • Integrated Delivery Network Profiles
  • Specialty Pharmacy Profiles

Account Relationships

  • Payer Benchmarking
  • Integrated Delivery Network Benchmarking

Patient Services

  • Autoimmune
  • Women’s Health
  • Orphan/Rare
  • Oncology

Special Topix

  • Oncology Pathways

Visit the Spherix portal for the full spectrum of our Market Access offering

Dermatology Indications Covered:

  • Alopecia Areata (AA)
  • Asthma
  • Atopic Dermatitis (AD)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Chronic Spontaneous Urticaria (CSU)
  • Hidradenitis Suppurativa (HS)
  • Plaque Psoriasis (PsO)
  • Prurigo Nodularis (PN)
  • Vitiligo

Visit the Spherix portal for the full spectrum of our Dermatology offering

Gastroenterology Indications Covered:

  • Celiac Disease
  • Cholestatic Pruritus
  • Crohn’s Disease
  • Eosinophilic Esophagitis
  • Inflammatory Bowel Disease
  • Irritable Bowel Syndrome
  • Metabolic Dysfunction–Associated Steatohepatitis (MASH)
  • Obesity
  • Primary Biliary Cholangitis
  • Ulcerative Colitis

Visit the Spherix portal for the full spectrum of our Gastroenterology offering

Rheumatology Indications Covered:

  • Ankylosing Spondylitis and nr-AxSpA
  • Cutaneous Lupus (CLE)
  • Giant Cell Arteritis (GCA)
  • Idiopathic Inflammatory Myopathies (IIM)
  • Lupus Nephritis
  • Psoriatic Arthritis (PsA)
  • Rheumatoid Arthritis
  • Sjogren’s Disease
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis (SSc)

Visit the Spherix portal for the full spectrum of our Rheumatology offering

Nephrology Indications Covered:

  • Chronic Kidney Disease, Non-Dialysis (CKD-ND)
  • Complement Disorders
  • Complement 3 Glomerulopathy (C3G)
  • Dialysis
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Hyperphosphatemia (HPhos)
  • IgA Nephropathy (IgAN)
  • Membranous Nephropathy (MN)
  • Renal Anemia
  • Transplant/AMR

Visit the Spherix portal for the full spectrum of our Nephrology offering

CNS Indications Covered:

  • Alzheimer’s Disease
  • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
  • Epilepsy
  • Generalized Myasthenia Gravis (gMG)
  • Major Depressive Disorder
  • Migraine
  • Multiple Sclerosis (MS)
  • Schizophrenia

Visit the Spherix portal for the full spectrum of our CNS offering

Ophthalmology Indications Covered:

  • Age-Related Macular Degeneration (AMD)
  • Diabetic Macular Edema (DME)
  • Diabetic Retinopathy

Visit the Spherix portal for the full spectrum of our Ophthalmology offering

Hematology Indications Covered:

  • Hemophilia A & B
  • Immune Thrombocytopenic Purpura (ITP)
  • Paroxysmal Nocturnal Hemoglobinuria
  • People with Bleeding Disorders
  • Sickle Cell Disease
  • Thalassemia
  • Warm Autoimmune Hemolytic Anemia (w-AIHA)
  • Willebrand Disease
  • Women, Girls, and people who have or have had the potential to menstruate (WGPPM) with Bleeding Disorders
Visit the Spherix portal for the full spectrum of our Hematology offering

Oncology Indications Covered:

  • Acute Myeloid Leukemia
  • B-Cell Malignancies
  • Chronic Lymphocytic Leukemia
  • Large B-Cell Lymphoma
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • Non-Small Cell Lung Cancer
  • PD-1 Inhibition in Solid Tumors
  • Smoldering Myeloma

Visit the Spherix portal for the full spectrum of our Oncology offering

Capitalize on commercially relevant therapeutic area-specific insights and advisory services across the pharma lifecycle.

Independent, holistic intelligence informs tailored support that matches the needs of your business.
Understand the prescriber’s perspective of the competitive landscape.
Reveal the ‘why’ behind treatment decisions and understand the patient journey.

Gain a holistic understanding of how patients experience, perceive, and navigate their condition.

Gain an unbiased perspective of the market and its potential.

Independently assess launches and benchmark history of analogs.

Add context to trending topics and gauge the impact of disruptive events.

Independent intelligence that translates market access complexity into commercially relevant action.

Identify best practices to build high-performing national and regional account teams and benchmark your performance against competitors.

Understand and predict market access trends and policy shifts affecting formulary management and reimbursement across commercial and government channels.

Gain strategic account intelligence on leading national and regional payers, IDNs, and specialty pharmacy accounts to support prioritization, engagement strategy, and planning.

Uncover best practices and comparative intelligence on indication and brand-level patient service programs and competencies.

Add context to trending topics and gauge the impact of disruptive events.

Independently assess launches and benchmark history of analogs.

Shape what’s next with market intelligence that is trusted and influential.

We work with 19 out of the top 20 pharmaceutical/biotech organizations, and our expertise is a go-to resource for leading brands, market access stakeholders, industry media outlets, financial analysts, professional organizations, and patient advocacy groups.
Learn more about the Spherix offering
  • Pharmaceutical and Biotech Companies
  • Key Opinion Leaders
  • Professional Organizations
  • Media Outlets
  • Patient Advocacy Groups
  • Financial Analyst Firms
  • Payer Key Decision Makers
  • Integrated Delivery Networks
  • Government Payers

Our experts are always just a click or call away...

  • Plugged into the ever-evolving landscape
  • Ready to provide an unbiased view of the landscape
  • Insightfully answer real-time questions
  • Highlight opportunities
  • Identify disruptors
Contact us
“Spherix's Dynamix studies provide us invaluable insights into the physician-patient exchange that guides both our patient-facing programs and our interactions with pharma partners. Their survey reports highlight needs that cannot be assessed by EMR data alone. They also reveal information and resources that patients are not receiving, gaps in support that we can fill. These reports are a glimpse into the patient exam room that we can't get anywhere else.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
"Spherix is unparalleled in their timely and accurate market snapshots with comprehensive feedback on physicians’ impressions, use patterns and projected use of key drugs across the therapeutic categories covered. They are my go-to source when I want insights as to how to model a launch, a competitive dynamic or understand awareness around pipeline agents.”
Senior Biotech Analyst at a Leading Investment Bank
"Spherix offerings have provided us with an external source of reference which, when compared with our custom market research, led us to include a potentially lucrative segment of physicians in our target list leading to increased growth.”
Pharmaceutical In-Line Brand Commercial Strategy Lead
"We incorporated Spherix’s insights into materials shared with two separate parties conducting diligence on our lead asset. Their work helped us clearly demonstrate the persistent unmet need in our lead indication, reinforcing the strength of our data with an independent, external perspective. The analysis added credibility and supported our conclusion that this therapeutic area continues to present significant opportunity.”
Chief Commercial Officer, Emerging Biotech Company
"In discussions with a potential partner exploring opportunities beyond our lead indication, Spherix’s analysis proved invaluable. Spherix’s comprehensive comparison of unmet needs across multiple conditions offered a uniquely credible and consistent dataset—something that’s rarely available when drawing from disparate sources. This foundation enabled a more robust and objective dialogue around the relative attractiveness and development potential of several key indications, ultimately helping us and our partner align on strategic priorities.”
Chief Commercial Officer, Emerging Biotech Company

Media

View all media

Talk to an expert

Sybil Mead
Vice President of Market Access

Contact

Andy Stankus
Franchise Head, Dermatology

Contact

Jim Hickey
Franchise Head, Gastroenterology

Contact

Lynn Price
Franchise Head, Rheumatology

Contact

Kari McCarthy
Franchise Head, Nephrology

Contact

Bob Shewbrooks
Franchise Head, CNS

Contact

Bob Shewbrooks
Franchise Head, Ophthalmology

Contact

Sarah Hendry
Franchise Head, Hematology

Contact

Sarah Hendry
Franchise Head, Oncology

Contact
Sign up for alerts, market insights and exclusive content in your inbox.